Research

(JUNE 4, 2019) The state’s three University of Vermont (UVM) Health Network hospitals are expanding access to treatment for patients with opioid use disorder with the support of a $1.5 million federal grant. The grant will support expansion of a program to offer rapid access to Medication-Assisted Treatment (MAT), such as buprenorphine, for opioid use disorder in the hospitals’ emergency departments.

(May 22, 2019) In an effort to understand why some people born in rural communities in the South live shorter and less healthy lives than their counterparts elsewhere in the same counties as well as across the country, researchers from the Larner College of Medicine at the University of Vermont at 11 other institutions will be participating in a new longitudinal cohort study aimed at combating this issue - the Risk Underlying Rural Areas Longitudinal Study (RURAL) .

(MAY 22, 2019) In April, the Vermont Department of Health, Vermont Center on Behavior and Health at the Larner College of Medicine at the University of Vermont (UVM), and UVM Cancer Center launched a new longitudinal pilot study, called PACE Vermont (Policy and Communication Evaluation Vermont), which is engaging young people ages 12 to 25 to help close the knowledge gap in effective substance use prevention efforts.

On April 30, 2019, UVM Distinguished Professor and Chair of Pharmacology Mark Nelson's achievements in original research were recognized with his election to membership in the prestigious National Academy of Sciences.

(APRIL 30, 2019) A new study, published Miller Chair of Palliative Medicine Robert Gramling, M.D., D.Sc., in the journal Psycho-Oncology, details how a seriously ill patient’s optimism can impact a clinician’s survival prognosis in palliative care conversations.

(APRIL 26, 2019) Russell P. Tracy, Ph.D., professor of pathology & laboratory medicine and biochemistry at the Larner College of Medicine at the University of Vermont, is among three faculty members who were selected for recognition as a University of Vermont Distinguished Professor at the UVM Main Commencement ceremony on May 19, 2019.

More than a dozen Larner College of Medicine faculty and scientists were recognized during the awards portion of the 14th annual Invention to Venture (I2V) conference April 5, 2019.

On Monday, April 8, Professor of Medicine Jason Bates, Ph.D., Sc.D., a world-class researcher and internationally recognized expert in the field of lung mechanics, will present his Research Laureate lecture, titled “A Physicist’s Approach to the Lung,” at noon in the Sullivan Classroom in the Medical Education Center at the Larner College of Medicine.

Twenty years ago, a small local chapter of the American Lung Association took on the daring task of bringing an Airways Clinical Research Center (ACRC) to Vermont. On February 28, clinicians, patients, donors, staff and board members gathered to celebrate two decades of lung disease treatment research in the only ACRC in a rural area - the Vermont Lung Center at UVM's ACRC, part of the nation’s largest not-for-profit network of clinical research centers dedicated to asthma and COPD treatment.

University of Vermont (UVM) Distinguished Professor and Chair of Pharmacology Mark Nelson, Ph.D., has been awarded a prestigious $6.45 million dollar Outstanding Investigator Award (OIA) from the National Heart, Lung and Blood Institute (NHLBI) at the National Institutes of Health. The award will provide support for Nelson’s research program, titled “Capillaries as a Sensory Web that Controls Cerebral Blood Flow in Health and Disease,” for seven years.